Dr. St. Geme's research focuses on bacterial pathogenesis, with an emphasis on defining the molecular and cellular determinants of Haemophilus influenzae and Kingella kingae disease.
CHOP researchers identify potential vaccine approach against nontypeable Haemophilus Influenzae (NTHi) — the most common cause of bacterial respiratory tract infection.
Despite its somewhat misleading name, H. influenzae does not cause influenza, but is instead associated with invasive infections and localized respiratory tract disease.
Noted microbiologist and Children's Hospital alumnus Joseph W. St. Geme, III, MD, was recently named CHOP's Physician-in-Chief and Chair of the Department of Pediatrics at the University of Pennsylvania. Dr. St. Geme, who officially started July 1, succeeds long-serving CHOP veteran Alan R. Cohen, MD, who held the post of Physician-in-Chief for 12 years.
The St. Geme Lab focuses on bacterial pathogenesis, with an emphasis on defining the molecular and cellular determinants of Haemophilus influenzae and Kingella kingae disease.
